Michael G. Palfreyman

Dr. Palfreyman is presently the Vice President of Research at Envivo. He co-founded NOVACE Corporation, a company dedicated to providing scientific, strategic and change management solutions to the biotechnology industry. Prior to that, he was Founder, President and CSO of Psychiatric Genomics, and CSO and Senior Vice President of Research & Development at Scriptgen Pharmaceuticals, Inc. Dr. Palfreyman held various leadership roles during his tenure at Marion Merrell Dow Research Institute including Head of CNS Research, Co-Chair Pipeline Evaluation Team, Vice President of Global Biological and Scientific Affairs, Vice President of Research. He was also the Head of Biochemical Pharmacology at Beecham Pharmaceuticals.